Thermo Fisher Completes $8.875 Billion Acquisition of Clario Holdings
Thermo Fisher Scientific completed the $8.875 billion acquisition of Clario Holdings. The deal was led by a shareholder group including Nordic Capital, Novo Holdings A/S, and others.
Thermo Fisher Scientific has completed the acquisition of Clario Holdings for $8.875 billion. A shareholder group led by Nordic Capital, Novo Holdings A/S, and others sold the company. This acquisition expands Thermo Fisher's clinical data offerings.
The deal highlights Thermo Fisher's strategic focus on expanding its portfolio through strategic acquisitions. The financial terms of the deal were already widely reported and confirm the completion of the transaction.
The completion of this acquisition reflects a significant transaction in the life sciences sector, further solidifying Thermo Fisher's position.
Powered by SentiSense - Intelligent Market Analysis